AFP and hepatocellular carcinoma: It is therefore important to explore the search for new biomarkers capable of overcoming the shortcomings of transaminases and AFP to complement X-ray examinations in the hope of achieving HCC screening rates close to those that would be obtained using the biopsy [22,30].